Inventor · disambiguated record
Laszlo Erno Kiss
Also filed as: KISS LASZLO · KISS LASZLO ERNO
18 granted patents·9 pending applications·113 citations·filing 2006–2022
93Inventor score
Files withBIAL PORTELA & CA SA12BIAL - PORTELA & CA S A6BIAL PORTELA & Cª S A4LEARMONTH DAVID ALEXANDER4KISS LASZLO ERNO1
Top patents by PatentIndex Score
27 records- 0192US8907099B2Nitrocatechol derivatives as COMT inhibitorsLEARMONTH DAVID ALEXANDER·Filed 2012·Granted Dec 9, 2014·16 cites·8 claims
- 0290US8168793B2Nitrocatechol derivatives as COMT inhibitorsLEARMONTH DAVID ALEXANDER·Filed 2006·Granted May 1, 2012·19 cites·16 claims
- 0389US9126988B2Intermediate for preparing a catechol-O-methyltransferase inhibitorBIAL PORTELA & CA SA·Filed 2012·Granted Sep 8, 2015·17 cites·30 claims
- 0487US8524746B2Dosage regimen for COMT inhibitorsLEARMONTH DAVID ALEXANDER·Filed 2007·Granted Sep 3, 2013·14 cites·17 claims
- 0585US9550759B2Nitrocatechol derivatives as COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2014·Granted Jan 24, 2017·5 cites·8 claims
- 0685US9446012B2Pharmaceutical compoundsBIAL-PORTELA & CA S A·Filed 2013·Granted Sep 20, 2016·7 cites·14 claims
- 0784US9630955B2Chemical compound useful as intermediate for preparing a catechol-O-methyltransferase inhibitorBIAL—PORTELA & Cª S A·Filed 2015·Granted Apr 25, 2017·7 cites·12 claims
- 0882US10023541B2Urea compounds and their use as enzyme inhibitorsBIAL PORTELA & CA SA·Filed 2016·Granted Jul 17, 2018·4 cites·8 claims
- 0982US9549915B2Urea compounds and their use as enzyme inhibitorsBIAL-PORTELA & CA S A·Filed 2013·Granted Jan 24, 2017·6 cites·5 claims
- 1082US8536203B2Pharmaceutical compoundsLEARMONTH DAVID ALEXANDER·Filed 2007·Granted Sep 17, 2013·12 cites·37 claims
- 1181US9745290B2Dosage regimen for COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2015·Granted Aug 29, 2017·3 cites·15 claims
- 1277US2022388999A1Nitrocatechol derivatives as comt inhibitorsBIAL PORTELA & CA SA·Filed 2022·Application pending·0 cites
- 1376US10336740B2Nitrocatechol derivatives as COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2017·Granted Jul 2, 2019·1 cites·16 claims
- 1470US2020102295A1Nitrocatechol derivatives as comt inhibitorsBIAL PORTELA & CA SA·Filed 2019·Application pending·0 cites
- 1566US2022017523A1BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-ß-HYDROXYLASE INHIBITORSBIAL PORTELA & CA SA·Filed 2021·Application pending·0 cites
- 1665US9353082B2Pharmaceutical compoundsKISS LASZLO ERNO·Filed 2009·Granted May 31, 2016·2 cites·64 claims
- 1764US2023138795A1Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & CA SA·Filed 2022·Application pending·0 cites
- 1863US11046654B2Urea compounds and their use as enzyme inhibitorsBIAL PORTELA & CA SA·Filed 2018·Granted Jun 29, 2021·0 cites·14 claims
- 1960US11034695B2Dopamine-β-hydroxylase inhibitorsBIAL—PORTELA & CA S A·Filed 2017·Granted Jun 15, 2021·0 cites·25 claims
- 2059US10975083B2Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitorsBIAL—PORTELA & Cᵃ S A·Filed 2017·Granted Apr 13, 2021·0 cites·21 claims
- 2158US2020255412A1Imidazolecarboxamides and Their Use as FAAH InhibitorsBIAL-PORTELA & CA SA·Filed 2019·Application pending·0 cites
- 2256US10501447B2Imidazolecarboxamides and their use as FAAH inhibitorsBIAL PORTELA & CA SA·Filed 2014·Granted Dec 10, 2019·0 cites·15 claims
- 2354US11434242B2Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & Cª S A·Filed 2018·Granted Sep 6, 2022·0 cites·14 claims
- 2454US2013331416A1Dosage regimen for comt inhibitorsBIAL PORTELA & CA SA·Filed 2013·Application pending·0 cites
- 2550US2010292482A1Novel precursorsBIAL PORTELA & CA SA·Filed 2008·Application pending·0 cites
- 2644US2022267331A1Dopamine-b-hydroxylase inhibitorsBIAL PORTELA & CA SA·Filed 2020·Application pending·0 cites
- 2737US2016166560A1Urea Compounds and Their Use as FAAH Enzyme InhibitorsBIAL PORTELA & Cª S A·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →